Yigit M, Sogut O, Lisar H, Yigit E
Department of Emergency Medicine, Haseki Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Department of Emergency Medicine, Midyat State Hospital, Mardin, Turkey.
Niger J Clin Pract. 2018 Apr;21(4):531-533. doi: 10.4103/njcp.njcp_177_17.
Hereditary angioedema is an autosomal-dominant disorder caused by mutation of the gene encoding the C1 esterase inhibitor (C1-INH). It manifests as painless, nonpruritic, nonpitting episodic swelling of the subcutaneous tissues, gastrointestinal, and upper respiratory tracts in the absence of urticaria. An attack typically takes 24 h to peak and resolves over 48-72 h. The most serious manifestation is a laryngeal attack associated with upper airway swelling. The aim of this case report is to describe the lifesaving use of a novel C1-INH protein concentrate in a patient with mild-to-moderate dyspnea caused by swelling of the upper airway (larynx) and tongue.
遗传性血管性水肿是一种常染色体显性疾病,由编码C1酯酶抑制剂(C1-INH)的基因突变引起。其表现为皮下组织、胃肠道和上呼吸道无痛性、非瘙痒性、非凹陷性发作性肿胀,且无荨麻疹。一次发作通常需要24小时达到高峰,并在48 - 72小时内消退。最严重的表现是与上呼吸道肿胀相关的喉部发作。本病例报告的目的是描述一种新型C1-INH蛋白浓缩物在一名因上呼吸道(喉部)和舌头肿胀导致轻至中度呼吸困难的患者中的救命应用。